As of January 2026, the China refurbished medical devices market is identifying as a pivotal pillar of the national "Green Healthcare" strategy, with a valuation expected to exceed $1.1 billion this year. The 2026 landscape is defined by the official implementation of the revised Good Manufacturing Practice (GMP) for Medical Devices, set to take effect on November 1, 2026, which introduces...